West Tower Group’s Abbott ABT Stock Holding History

West Tower Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,300	Closed	-$262K	–	77
2024 Q3	$262K	Buy	+2,300	New	+$252K	0.56%	66
2023 Q4	–	Sell	-359	Closed	-$34.8K	–	491
2023 Q3	$34.8K	Buy	+359	New	+$37.7K	0.02%	259

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

West Tower Group's ABT Position: Q4 2024 in Review

West Tower Group sold out of Abbott (ABT) in Q4 2024, closing a stake of 2,300 shares — an estimated $262K sold.

West Tower Group first reported a position in ABT in Q3 2023 and held it in 2 quarters. The position peaked at $262K in Q3 2024. 3,065 funds tracked by Wall St. Rank hold ABT as of Q4 2024.

West Tower Group reported no remaining Abbott position as of Q4 2024 after selling out during the quarter.
West Tower Group sold 2,300 Abbott shares in Q4 2024, an estimated $262K.
West Tower Group first reported a position in Abbott in Q3 2023 and held it in 2 quarters.
West Tower Group's Abbott position peaked at $262K in Q3 2024.
3,065 funds tracked by Wall St. Rank held Abbott as of Q4 2024.

Based on West Tower Group's 13F filing for Q4 2024, filed 11 Feb 2025.